APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antiviral Drug Packaging

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antiviral Drug Packaging Industry Growth and Trends Forecast to 2032

25 December 2025107 pages

Choose your research edition.

Industry ResearchAntiviral Drug Packaging Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Antiviral Drug Packaging Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Antiviral Drug Packaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antiviral Drug Packaging Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Antiviral Drug Packaging Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Antiviral Drug Packaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antiviral Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antiviral Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antiviral Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antiviral Drug Packaging include Avery Dennison Corporation, E.I. du Pont de Nemours, CCL Industries Inc, BioCote, Avient, Mondi, Biomaster, BASF and Lonza, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antiviral Drug Packaging market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antiviral Drug Packaging market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antiviral Drug Packaging market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antiviral Drug Packaging.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antiviral Drug Packaging market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antiviral Drug Packaging Market by Company

Avery Dennison Corporation

E.I. du Pont de Nemours

CCL Industries Inc

BioCote

Avient

Mondi

Biomaster

BASF

Lonza

Takex Labo Co. Ltd

Berry

Lageen Tubes.

Antiviral Drug Packaging Segment by Type

Rigid Plastic

Flexible Blister Foils

Others

Antiviral Drug Packaging Segment by Application

Pharmaceuticals

Healthcare

Antiviral Drug Packaging Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiviral Drug Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antiviral Drug Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiviral Drug Packaging.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antiviral Drug Packaging manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antiviral Drug Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Rigid Plastic Table 2. Major Company of Flexible Blister Foils Table 3. Major Company of Others Table 4. Global Antiviral Drug Packaging Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Antiviral Drug Packaging Sales by Type (2021-2026) & (k units) Table 6. Global Antiviral Drug Packaging Sales Market Share in Volume by Type (2021-2026) Table 7. Global Antiviral Drug Packaging Sales by Type (2021-2026) & (US$ Million) Table 8. Global Antiviral Drug Packaging Sales Market Share in Value by Type (2021-2026) Table 9. Global Antiviral Drug Packaging Price by Type (2021-2026) & (USD/unit) Table 10. Global Antiviral Drug Packaging Sales by Type (2027-2032) & (k units) Table 11. Global Antiviral Drug Packaging Sales Market Share in Volume by Type (2027-2032) Table 12. Global Antiviral Drug Packaging Sales by Type (2027-2032) & (US$ Million) Table 13. Global Antiviral Drug Packaging Sales Market Share in Value by Type (2027-2032) Table 14. Global Antiviral Drug Packaging Price by Type (2027-2032) & (USD/unit) Table 15. North America Antiviral Drug Packaging Sales by Type (2021-2026) & (k units) Table 16. North America Antiviral Drug Packaging Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Antiviral Drug Packaging Sales by Type (2021-2026) & (k units) Table 18. Europe Antiviral Drug Packaging Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Antiviral Drug Packaging Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Antiviral Drug Packaging Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Antiviral Drug Packaging Sales by Type (2021-2026) & (k units) Table 22. Latin America Antiviral Drug Packaging Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Antiviral Drug Packaging Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Antiviral Drug Packaging Sales by Type (2021-2026) & (US$ Million) Table 25. Antiviral Drug Packaging Industry Trends Table 26. Antiviral Drug Packaging Industry Drivers Table 27. Antiviral Drug Packaging Industry Opportunities and Challenges Table 28. Antiviral Drug Packaging Industry Restraints Table 29. Global Antiviral Drug Packaging Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Antiviral Drug Packaging Revenue Market Share by Company (2021-2026) Table 31. Global Antiviral Drug Packaging Sales by Company (2021-2026) & (k units) Table 32. Global Antiviral Drug Packaging Sales Share by Company (2021-2026) Table 33. Global Antiviral Drug Packaging Market Price by Company (2021-2026) & (USD/unit) Table 34. Global Antiviral Drug Packaging Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Antiviral Drug Packaging Major Company Production Sites and Headquarters Table 36. Global Antiviral Drug Packaging Company, Product Type & Application Table 37. Global Antiviral Drug Packaging Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Antiviral Drug Packaging by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Antiviral Drug Packaging Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Antiviral Drug Packaging Sales by Region (2021-2026) & (k units) Table 42. Global Antiviral Drug Packaging Sales Market Share in Volume by Region (2021-2026) Table 43. Global Antiviral Drug Packaging Sales by Region (2021-2026) & (US$ Million) Table 44. Global Antiviral Drug Packaging Sales Market Share in Value by Region (2021-2026) Table 45. Global Antiviral Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Global Antiviral Drug Packaging Sales by Region (2027-2032) & (k units) Table 47. Global Antiviral Drug Packaging Sales Market Share in Volume by Region (2027-2032) Table 48. Global Antiviral Drug Packaging Sales by Region (2027-2032) & (US$ Million) Table 49. Global Antiviral Drug Packaging Sales Market Share in Value by Region (2027-2032) Table 50. Global Antiviral Drug Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 51. Global Antiviral Drug Packaging Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Antiviral Drug Packaging Sales by Application (2021-2026) & (k units) Table 53. Global Antiviral Drug Packaging Sales Market Share in Volume by Application (2021-2026) Table 54. Global Antiviral Drug Packaging Sales by Application (2021-2026) & (US$ Million) Table 55. Global Antiviral Drug Packaging Sales Market Share in Value by Application (2021-2026) Table 56. Global Antiviral Drug Packaging Price by Application (2021-2026) & (USD/unit) Table 57. Global Antiviral Drug Packaging Sales by Application (2027-2032) & (k units) Table 58. Global Antiviral Drug Packaging Sales Market Share in Volume by Application (2027-2032) Table 59. Global Antiviral Drug Packaging Sales by Application (2027-2032) & (US$ Million) Table 60. Global Antiviral Drug Packaging Sales Market Share in Value by Application (2027-2032) Table 61. Global Antiviral Drug Packaging Price by Application (2027-2032) & (USD/unit) Table 62. North America Antiviral Drug Packaging Sales by Application (2021-2026) & (k units) Table 63. North America Antiviral Drug Packaging Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Antiviral Drug Packaging Sales by Application (2021-2026) & (k units) Table 65. Europe Antiviral Drug Packaging Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Antiviral Drug Packaging Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Antiviral Drug Packaging Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Antiviral Drug Packaging Sales by Application (2021-2026) & (k units) Table 69. Latin America Antiviral Drug Packaging Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Antiviral Drug Packaging Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Antiviral Drug Packaging Sales by Application (2021-2026) & (US$ Million) Table 72. Avery Dennison Corporation Company Information Table 73. Avery Dennison Corporation Business Overview Table 74. Avery Dennison Corporation Antiviral Drug Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Avery Dennison Corporation Antiviral Drug Packaging Product Portfolio Table 76. Avery Dennison Corporation Recent Development Table 77. E.I. du Pont de Nemours Company Information Table 78. E.I. du Pont de Nemours Business Overview Table 79. E.I. du Pont de Nemours Antiviral Drug Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. E.I. du Pont de Nemours Antiviral Drug Packaging Product Portfolio Table 81. E.I. du Pont de Nemours Recent Development Table 82. CCL Industries Inc Company Information Table 83. CCL Industries Inc Business Overview Table 84. CCL Industries Inc Antiviral Drug Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. CCL Industries Inc Antiviral Drug Packaging Product Portfolio Table 86. CCL Industries Inc Recent Development Table 87. BioCote Company Information Table 88. BioCote Business Overview Table 89. BioCote Antiviral Drug Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. BioCote Antiviral Drug Packaging Product Portfolio Table 91. BioCote Recent Development Table 92. Avient Company Information Table 93. Avient Business Overview Table 94. Avient Antiviral Drug Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Avient Antiviral Drug Packaging Product Portfolio Table 96. Avient Recent Development Table 97. Mondi Company Information Table 98. Mondi Business Overview Table 99. Mondi Antiviral Drug Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Mondi Antiviral Drug Packaging Product Portfolio Table 101. Mondi Recent Development Table 102. Biomaster Company Information Table 103. Biomaster Business Overview Table 104. Biomaster Antiviral Drug Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Biomaster Antiviral Drug Packaging Product Portfolio Table 106. Biomaster Recent Development Table 107. BASF Company Information Table 108. BASF Business Overview Table 109. BASF Antiviral Drug Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. BASF Antiviral Drug Packaging Product Portfolio Table 111. BASF Recent Development Table 112. Lonza Company Information Table 113. Lonza Business Overview Table 114. Lonza Antiviral Drug Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Lonza Antiviral Drug Packaging Product Portfolio Table 116. Lonza Recent Development Table 117. Takex Labo Co. Ltd Company Information Table 118. Takex Labo Co. Ltd Business Overview Table 119. Takex Labo Co. Ltd Antiviral Drug Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Takex Labo Co. Ltd Antiviral Drug Packaging Product Portfolio Table 121. Takex Labo Co. Ltd Recent Development Table 122. Berry Company Information Table 123. Berry Business Overview Table 124. Berry Antiviral Drug Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Berry Antiviral Drug Packaging Product Portfolio Table 126. Berry Recent Development Table 127. Lageen Tubes. Company Information Table 128. Lageen Tubes. Business Overview Table 129. Lageen Tubes. Antiviral Drug Packaging Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Lageen Tubes. Antiviral Drug Packaging Product Portfolio Table 131. Lageen Tubes. Recent Development Table 132. North America Antiviral Drug Packaging Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 133. North America Antiviral Drug Packaging Sales by Country (2021-2026) & (k units) Table 134. North America Antiviral Drug Packaging Sales Market Share by Country (2021-2026) Table 135. North America Antiviral Drug Packaging Sales Forecast by Country (2027-2032) & (k units) Table 136. North America Antiviral Drug Packaging Sales Market Share Forecast by Country (2027-2032) Table 137. North America Antiviral Drug Packaging Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America Antiviral Drug Packaging Market Size by Country (2021-2026) & (US$ Million) Table 139. North America Antiviral Drug Packaging Market Share by Country (2021-2026) Table 140. North America Antiviral Drug Packaging Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America Antiviral Drug Packaging Market Share Forecast by Country (2027-2032) Table 142. Europe Antiviral Drug Packaging Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 143. Europe Antiviral Drug Packaging Sales by Country (2021-2026) & (k units) Table 144. Europe Antiviral Drug Packaging Sales Market Share by Country (2021-2026) Table 145. Europe Antiviral Drug Packaging Sales Forecast by Country (2027-2032) & (k units) Table 146. Europe Antiviral Drug Packaging Sales Market Share Forecast by Country (2027-2032) Table 147. Europe Antiviral Drug Packaging Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe Antiviral Drug Packaging Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe Antiviral Drug Packaging Market Share by Country (2021-2026) Table 150. Europe Antiviral Drug Packaging Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe Antiviral Drug Packaging Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Antiviral Drug Packaging Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Antiviral Drug Packaging Sales by Country (2021-2026) & (k units) Table 154. Asia-Pacific Antiviral Drug Packaging Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific Antiviral Drug Packaging Sales Forecast by Country (2027-2032) & (k units) Table 156. Asia-Pacific Antiviral Drug Packaging Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Antiviral Drug Packaging Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Antiviral Drug Packaging Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific Antiviral Drug Packaging Market Share by Country (2021-2026) Table 160. Asia-Pacific Antiviral Drug Packaging Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific Antiviral Drug Packaging Market Share Forecast by Country (2027-2032) Table 162. Latin America Antiviral Drug Packaging Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 163. Latin America Antiviral Drug Packaging Sales by Country (2021-2026) & (k units) Table 164. Latin America Antiviral Drug Packaging Sales Market Share by Country (2021-2026) Table 165. Latin America Antiviral Drug Packaging Sales Forecast by Country (2027-2032) & (k units) Table 166. Latin America Antiviral Drug Packaging Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America Antiviral Drug Packaging Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America Antiviral Drug Packaging Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America Antiviral Drug Packaging Market Share by Country (2021-2026) Table 170. Latin America Antiviral Drug Packaging Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America Antiviral Drug Packaging Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Antiviral Drug Packaging Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Antiviral Drug Packaging Sales by Country (2021-2026) & (k units) Table 174. Middle East and Africa Antiviral Drug Packaging Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa Antiviral Drug Packaging Sales Forecast by Country (2027-2032) & (k units) Table 176. Middle East and Africa Antiviral Drug Packaging Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Antiviral Drug Packaging Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Antiviral Drug Packaging Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa Antiviral Drug Packaging Market Share by Country (2021-2026) Table 180. Middle East and Africa Antiviral Drug Packaging Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa Antiviral Drug Packaging Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Antiviral Drug Packaging Distributors List Table 185. Antiviral Drug Packaging Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Antiviral Drug Packaging Image Figure 2. Global Antiviral Drug Packaging Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antiviral Drug Packaging Market Size (2021-2032) & (US$ Million) Figure 4. Global Antiviral Drug Packaging Sales (2021-2032) & (k units) Figure 5. Rigid Plastic Image Figure 6. Global Rigid Plastic Sales YoY Growth (2021-2032) & (k units) Figure 7. Flexible Blister Foils Image Figure 8. Global Flexible Blister Foils Sales YoY Growth (2021-2032) & (k units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Antiviral Drug Packaging Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Antiviral Drug Packaging Market Share by Type 2025 VS 2032 Figure 13. North America Antiviral Drug Packaging Sales Market Share in Volume by Type in 2025 Figure 14. North America Antiviral Drug Packaging Sales Market Share in Value by Type in 2025 Figure 15. Europe Antiviral Drug Packaging Sales Market Share in Volume by Type in 2025 Figure 16. Europe Antiviral Drug Packaging Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Antiviral Drug Packaging Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Antiviral Drug Packaging Sales Market Share in Value by Type in 2025 Figure 19. Latin America Antiviral Drug Packaging Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Antiviral Drug Packaging Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Antiviral Drug Packaging Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Antiviral Drug Packaging Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Antiviral Drug Packaging Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Pharmaceuticals Image Figure 26. Global Pharmaceuticals Sales YoY Growth (2021-2032) & (k units) Figure 27. Healthcare Image Figure 28. Global Healthcare Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Antiviral Drug Packaging Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Antiviral Drug Packaging Market Share by Application 2025 VS 2032 Figure 31. North America Antiviral Drug Packaging Sales Market Share in Volume by Application in 2025 Figure 32. North America Antiviral Drug Packaging Sales Market Share in Value by Application in 2025 Figure 33. Europe Antiviral Drug Packaging Sales Market Share in Volume by Application in 2025 Figure 34. Europe Antiviral Drug Packaging Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Antiviral Drug Packaging Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Antiviral Drug Packaging Sales Market Share in Value by Application in 2025 Figure 37. Latin America Antiviral Drug Packaging Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Antiviral Drug Packaging Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Antiviral Drug Packaging Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Antiviral Drug Packaging Sales Market Share in Value by Application in 2025 Figure 41. North America Antiviral Drug Packaging Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Antiviral Drug Packaging Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Antiviral Drug Packaging Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Antiviral Drug Packaging Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Antiviral Drug Packaging Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Antiviral Drug Packaging Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Antiviral Drug Packaging Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Antiviral Drug Packaging Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Antiviral Drug Packaging Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Antiviral Drug Packaging Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Antiviral Drug Packaging Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Antiviral Drug Packaging Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Antiviral Drug Packaging Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Antiviral Drug Packaging Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Antiviral Drug Packaging Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Antiviral Drug Packaging Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Antiviral Drug Packaging Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Antiviral Drug Packaging Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Antiviral Drug Packaging Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Antiviral Drug Packaging Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Antiviral Drug Packaging Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Antiviral Drug Packaging Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Rigid Plastic
  • Flexible Blister Foils
  • Others
Applications
  • Pharmaceuticals
  • Healthcare
Companies covered
  • Avery Dennison Corporation
  • E.I. du Pont de Nemours
  • CCL Industries Inc
  • BioCote
  • Avient
  • Mondi
  • Biomaster
  • BASF
  • Lonza
  • Takex Labo Co. Ltd
  • Berry
  • Lageen Tubes.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antiviral Drug Packaging Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antiviral Drug Packaging Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antiviral Drug Packaging Market by Type
  6. 1.3.1 Rigid Plastic
  7. 1.3.2 Flexible Blister Foils
  8. 1.3.3 Others
  9. 1.4 Global Antiviral Drug Packaging Market Size by Type
  10. 1.4.1 Global Antiviral Drug Packaging Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Antiviral Drug Packaging Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Antiviral Drug Packaging Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Antiviral Drug Packaging Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Antiviral Drug Packaging Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Antiviral Drug Packaging Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Antiviral Drug Packaging Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Antiviral Drug Packaging Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antiviral Drug Packaging Industry Trends
  2. 2.2 Antiviral Drug Packaging Industry Drivers
  3. 2.3 Antiviral Drug Packaging Industry Opportunities and Challenges
  4. 2.4 Antiviral Drug Packaging Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antiviral Drug Packaging Revenue (2021-2026)
  2. 3.2 Global Top Players by Antiviral Drug Packaging Sales (2021-2026)
  3. 3.3 Global Top Players by Antiviral Drug Packaging Price (2021-2026)
  4. 3.4 Global Antiviral Drug Packaging Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antiviral Drug Packaging Major Company Production Sites & Headquarters
  6. 3.6 Global Antiviral Drug Packaging Company, Product Type & Application
  7. 3.7 Global Antiviral Drug Packaging Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antiviral Drug Packaging Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antiviral Drug Packaging Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antiviral Drug Packaging Tier 1, Tier 2, and Tier 3
4 Antiviral Drug Packaging Regional Status and Outlook
  1. 4.1 Global Antiviral Drug Packaging Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antiviral Drug Packaging Historic Market Size by Region
  3. 4.2.1 Global Antiviral Drug Packaging Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antiviral Drug Packaging Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antiviral Drug Packaging Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antiviral Drug Packaging Forecasted Market Size by Region
  7. 4.3.1 Global Antiviral Drug Packaging Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antiviral Drug Packaging Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antiviral Drug Packaging Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antiviral Drug Packaging by Application
  1. 5.1 Antiviral Drug Packaging Market by Application
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Healthcare
  4. 5.2 Global Antiviral Drug Packaging Market Size by Application
  5. 5.2.1 Global Antiviral Drug Packaging Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Antiviral Drug Packaging Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Antiviral Drug Packaging Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Antiviral Drug Packaging Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Antiviral Drug Packaging Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Antiviral Drug Packaging Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Antiviral Drug Packaging Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Antiviral Drug Packaging Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Avery Dennison Corporation
  2. 6.1.1 Avery Dennison Corporation Company Information
  3. 6.1.2 Avery Dennison Corporation Business Overview
  4. 6.1.3 Avery Dennison Corporation Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Avery Dennison Corporation Antiviral Drug Packaging Product Portfolio
  6. 6.1.5 Avery Dennison Corporation Recent Developments
  7. 6.2 E.I. du Pont de Nemours
  8. 6.2.1 E.I. du Pont de Nemours Company Information
  9. 6.2.2 E.I. du Pont de Nemours Business Overview
  10. 6.2.3 E.I. du Pont de Nemours Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 E.I. du Pont de Nemours Antiviral Drug Packaging Product Portfolio
  12. 6.2.5 E.I. du Pont de Nemours Recent Developments
  13. 6.3 CCL Industries Inc
  14. 6.3.1 CCL Industries Inc Company Information
  15. 6.3.2 CCL Industries Inc Business Overview
  16. 6.3.3 CCL Industries Inc Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CCL Industries Inc Antiviral Drug Packaging Product Portfolio
  18. 6.3.5 CCL Industries Inc Recent Developments
  19. 6.4 BioCote
  20. 6.4.1 BioCote Company Information
  21. 6.4.2 BioCote Business Overview
  22. 6.4.3 BioCote Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 BioCote Antiviral Drug Packaging Product Portfolio
  24. 6.4.5 BioCote Recent Developments
  25. 6.5 Avient
  26. 6.5.1 Avient Company Information
  27. 6.5.2 Avient Business Overview
  28. 6.5.3 Avient Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Avient Antiviral Drug Packaging Product Portfolio
  30. 6.5.5 Avient Recent Developments
  31. 6.6 Mondi
  32. 6.6.1 Mondi Company Information
  33. 6.6.2 Mondi Business Overview
  34. 6.6.3 Mondi Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Mondi Antiviral Drug Packaging Product Portfolio
  36. 6.6.5 Mondi Recent Developments
  37. 6.7 Biomaster
  38. 6.7.1 Biomaster Company Information
  39. 6.7.2 Biomaster Business Overview
  40. 6.7.3 Biomaster Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Biomaster Antiviral Drug Packaging Product Portfolio
  42. 6.7.5 Biomaster Recent Developments
  43. 6.8 BASF
  44. 6.8.1 BASF Company Information
  45. 6.8.2 BASF Business Overview
  46. 6.8.3 BASF Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 BASF Antiviral Drug Packaging Product Portfolio
  48. 6.8.5 BASF Recent Developments
  49. 6.9 Lonza
  50. 6.9.1 Lonza Company Information
  51. 6.9.2 Lonza Business Overview
  52. 6.9.3 Lonza Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Lonza Antiviral Drug Packaging Product Portfolio
  54. 6.9.5 Lonza Recent Developments
  55. 6.10 Takex Labo Co. Ltd
  56. 6.10.1 Takex Labo Co. Ltd Company Information
  57. 6.10.2 Takex Labo Co. Ltd Business Overview
  58. 6.10.3 Takex Labo Co. Ltd Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Takex Labo Co. Ltd Antiviral Drug Packaging Product Portfolio
  60. 6.10.5 Takex Labo Co. Ltd Recent Developments
  61. 6.11 Berry
  62. 6.11.1 Berry Company Information
  63. 6.11.2 Berry Business Overview
  64. 6.11.3 Berry Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Berry Antiviral Drug Packaging Product Portfolio
  66. 6.11.5 Berry Recent Developments
  67. 6.12 Lageen Tubes.
  68. 6.12.1 Lageen Tubes. Company Information
  69. 6.12.2 Lageen Tubes. Business Overview
  70. 6.12.3 Lageen Tubes. Antiviral Drug Packaging Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Lageen Tubes. Antiviral Drug Packaging Product Portfolio
  72. 6.12.5 Lageen Tubes. Recent Developments
7 North America by Country
  1. 7.1 North America Antiviral Drug Packaging Sales by Country
  2. 7.1.1 North America Antiviral Drug Packaging Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antiviral Drug Packaging Sales by Country (2021-2026)
  4. 7.1.3 North America Antiviral Drug Packaging Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antiviral Drug Packaging Market Size by Country
  6. 7.2.1 North America Antiviral Drug Packaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antiviral Drug Packaging Market Size by Country (2021-2026)
  8. 7.2.3 North America Antiviral Drug Packaging Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antiviral Drug Packaging Sales by Country
  2. 8.1.1 Europe Antiviral Drug Packaging Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antiviral Drug Packaging Sales by Country (2021-2026)
  4. 8.1.3 Europe Antiviral Drug Packaging Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antiviral Drug Packaging Market Size by Country
  6. 8.2.1 Europe Antiviral Drug Packaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antiviral Drug Packaging Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antiviral Drug Packaging Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antiviral Drug Packaging Sales by Country
  2. 9.1.1 Asia-Pacific Antiviral Drug Packaging Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antiviral Drug Packaging Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antiviral Drug Packaging Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antiviral Drug Packaging Market Size by Country
  6. 9.2.1 Asia-Pacific Antiviral Drug Packaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antiviral Drug Packaging Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antiviral Drug Packaging Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antiviral Drug Packaging Sales by Country
  2. 10.1.1 South America Antiviral Drug Packaging Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antiviral Drug Packaging Sales by Country (2021-2026)
  4. 10.1.3 South America Antiviral Drug Packaging Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antiviral Drug Packaging Market Size by Country
  6. 10.2.1 South America Antiviral Drug Packaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antiviral Drug Packaging Market Size by Country (2021-2026)
  8. 10.2.3 South America Antiviral Drug Packaging Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antiviral Drug Packaging Sales by Country
  2. 11.1.1 Middle East and Africa Antiviral Drug Packaging Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antiviral Drug Packaging Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antiviral Drug Packaging Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antiviral Drug Packaging Market Size by Country
  6. 11.2.1 Middle East and Africa Antiviral Drug Packaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antiviral Drug Packaging Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antiviral Drug Packaging Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antiviral Drug Packaging Value Chain Analysis
  2. 12.1.1 Antiviral Drug Packaging Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antiviral Drug Packaging Production Mode & Process
  7. 12.2 Antiviral Drug Packaging Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antiviral Drug Packaging Distributors
  10. 12.2.3 Antiviral Drug Packaging Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst